internal-medicine-breast-pathology-2018-posters

6 / 26

Page 48
Notes:
alliedacademies
Archives of General Internal Medicine | Volume 2
&
April 04-05, 2018 | Miami, USA
International Conference on
Internal Medicine & Practice and Primary Care
International Meeting on
Breast Pathology & Cancer Diagnosis
Introduction: Cardiac arrhythmias among hospitalized
patients are a common problem in the hospitals. Big part
is associated with drug-inducing long QT (DILQT). DILQT are
widely used in inpatient and outpatient settings. Our research
project aimed to assess the monitoring of QTc-interval as a
primary preventive mechanism for DILQT-associated cardiac
arrhythmias among hospitalized patients in a community
hospital.
Methods: This retrospective study included data obtained
frompatientswhohadadiagnosisofcardiacarrest,ventricular
tachycardia, and/or syncope while hospitalized between
January 1, 2013 and December 31, 2016. Descriptive analysis
was performed to assess the proportions of patients who
were on two or more of QT interval prolonging medications
and had the aforementioned outcomes.
Results: The numbers of patients who had a diagnosis of
cardiac arrest, ventricular tachycardia, and/or syncope were
3,583 in 2013, 3,828 in 2014, 4,105 in 2015, and 4,376 in
2016. Of those, approximately 256 (7.1%) in 2013, 241
(6.3%) in 2014, 268 (6.5%) in 2015, and 263 (6.0%) in 2016
were on two or more of QT interval prolonging medications.
It was noted that patients on two or more DILQT had higher
proportions of ventricular tachycardia compared cardiac
arrest or syncope in all the years. Less than 10% of the
patients on two or more QT prolonging medications received
an EKG on admission or anytime during their admission in all
the years.
Conclusion: This study, which provides the preliminary
data for a quality improvement study, shows that there are
missed opportunities to prevent DILQT-associated cardiac
arrhythmias among hospitalized patients on two or more
QT interval prolonging medications. Power chart pop-up
message will fire when prescriber will order DILQT while the
patient is on one or more of DILQT advising the prescriber
to check QTc of the patient. Another study to compare the
arrhythmia incidence after the intervention application.
Speaker Biography
Ahmed Elshazly MD has graduated from medical school during 2012. He then was a
research fellow for 2 years at Albert Einstein College of Medicine, Mayo Clinic and West
Virginia University. He is currently pursuing Internal Medicine residency at Atlantic
Care Regional Hospital, Atlantic City, NJ.
e:
Drug-induced long QT associated cardiac arrhythmias among adult patients in a community hospital
Ahmed Elshazly
Atlantic Care Regional Hospital, USA